Drugs · acquisition-cost intelligence
ZERVIATE
cetirizine· ingredient cetirizineOther antiallergics· CETIRIZINE 2.4 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$7.33
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 4 weeks.
2025-11-052026-05-20
Same-ingredient options by acquisition cost
Other cetirizine products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| All Day Allergy | $0.02152 | −$7.31 |
| Cetirizine HCl | $0.04795 | −$7.29 |
| 24 hour allergy | $0.06400 | −$7.27 |
| 24 hour allergy | $0.19380 | −$7.14 |
| 12 hour allergy d | $0.58890 | −$6.74 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.